Cancer scare weighs on Le Clos ahead of Phelps re-match

South Africa's le Clos celebrates gold in the men's 100m butterfly final at the Aquatics World Championships in KazanBy Mark Gleeson CAPE TOWN (Reuters) - Chad le Clos's much-anticipated re-match with superstar Michael Phelps in Rio de Janeiro's Olympic pool is clouded by a family health scare that hangs heavily over the 24-year-old South African. Le Clos announced earlier this month that both his parents were being treated for cancer, casting an emotive shadow over his preparations for Brazil where the 200 meters butterfly duel is arguably the must-see event at the Olympic Aquatics Stadium in Barra da Tijuca. Le Clos narrowly pipped the American in the race at London, a dramatic victory that catapulted the youngster and his colorful father Bert into the spotlight.



Police want to use 3D fingerprint replicas to access murder victim’s iPhone
A few months ago, Apple was embroiled in a high-publicized legal battle with the FBI over mobile security. If you recall, the controversy began after Apple refused to create a custom version of iOS that would have enabled authorities to bypass the lockscreen on the iPhone used by one of the San Bernardino terrorists. In defending Apple's position, Tim Cook boldly said that the FBI wanted Apple to create the " software equivalent of cancer ." Ultimately, the legal dispute fizzled out after the FBI managed to purchase software from a third-party that enabled it to bypass the lockscreen without Apple's assistance. With that as a backdrop, we recently stumbled upon a report detailing a novel way that law enforcement authorities in Michigan managed to access a locked iPhone of a murder victim, without any help from Apple or even having to lay out hundreds of thousands of dollars to a third-party. DON'T MISS:  Pokemon Go: Google Maps hack makes it easier than ever to find Pokémon According to a report from Fusion , Police in Michigan recently needed access to the locked iPhone belonging to a murder victim. Naturally, the authorities believe that information on the phone may provide them clues and help them solve the ongoing murder investigation. Initially thwarted by the Touch ID system the user had set up on his phone, the police did not reach out to Apple but instead contacted a Michigan State University Computer Science professor named Anil Jain who had substantial expertise in biometric related technologies. In turn, Jain, along with help from a PhD student named Sunpreet Arora, utilized 3D printing to create a replica version of the victim’s fingerprints based on prints the police already had on file. And because authorities aren’t sure which digit the victim used to access his phone, Jain has been busy creating replicas of all of the victim’s fingers. But of course, that’s just part one of the process. Because Touch ID on the iPhone is only receptive to an object with electrical current, a dummy replica of a fingerprint, no matter how accurate, is not sufficient to access the device in and of itself. That said, there is a solution in the works. Most fingerprint readers used on phones are capacitive, which means they rely on the closing of tiny electrical circuits to work. The ridges of your fingers cause some of these circuits to come in contact with each other, generating an image of the fingerprint. Skin is conductive enough to close these circuits, but the normal 3D printing plastic isn’t, so Arora coated the 3D printed fingers in a thin layer of metallic particles so that the fingerprint scanner can read them. It’s not a foolproof method yet. Arora is still refining the technology, and they haven’t yet given the fingers back to the police to try and unlock the victim’s phone. But Arora said that in a few weeks, once he’s tested the fingers enough in the lab, he’ll hand them over. Then the police will try to use 3D printed models of a dead man’s fingers to unlock his phone. All in all, that’s a pretty clever workaround, but the entire process might be all for naught. Remember, iPhones that have been turned off for more than 48 hours require a passcode for full access to the device. Which, of course, will simply bring the police back to square one and in the same position as the FBI was in a few months ago.

Swimming-Cancer scare weighs on Le Clos ahead of Phelps re-match
By Mark Gleeson CAPE TOWN, July 23 (Reuters) - Chad le Clos's much-anticipated re-match with superstar Michael Phelps in Rio de Janeiro's Olympic pool is clouded by a family health scare that hangs heavily over the 24-year-old South African. Le Clos announced earlier this month that both his parents were being treated for cancer, casting an emotive shadow over his preparations for Brazil where the 200 metres butterfly duel is arguably the must-see event at the Olympic Aquatics Stadium in Barra da Tijuca. Le Clos narrowly pipped the American in the race at London, a dramatic victory that catapulted the youngster and his colourful father Bert into the spotlight.

Chinese scientists will be the first to use CRISPR gene editing in human patients

Chinese scientists will be the first to use CRISPR gene editing in human patientsChinese scientists next month will treat lung cancer patients with immune cells modified using the CRISPR–Cas9 gene editing technique. The world's first human trials will establish whether CRISPR is a viable option for patients not responding to conventional treatment.



Alcohol's cancer risks outweigh any health benefits, study shows

Alcohol's cancer risks outweigh any health benefits, study showsDrinking alcohol is a direct cause of at least seven forms of cancer, and the more you drink, the higher your risk, a new analysis found.  The report’s author said she hoped to cut through the barrage of studies and stories that can leave readers with conflicting views of alcohol’s effects.  After all, isn’t a nightly glass of wine supposed to be good for you? SEE ALSO: Couples who get drunk together, stay together, according to a new study “There is no argument, on current evidence, for a safe level of drinking with respect to cancer,” Jennie Connor , the author and a professor of epidemiology at Otago University in New Zealand, wrote in the analysis, published Thursday in the scientific journal Addiction . She added that studies touting the perceived health benefits of casual drinking are “seen increasingly as disingenuous or irrelevant,” given the rising risks of a range of cancers. Connor’s report found there is strong evidence that alcohol causes cancer of the liver, colon, rectum, esophagus, larynx, pharynx and female breast. A 1.5-ounce shot of 80-proof liquor equals one drink. Image: Getty Images/EyeEm Premium Her conclusions are based on comprehensive research and analyses carried out in the last decade by groups such as the World Cancer Research Fund, a U.K.-based nonprofit, and the International Agency for Research on Cancer, an arm of the World Health Organization in France.  Scientists at the agency similarly highlighted the link between alcohol and the same seven cancers in a 2013 paper published in the journal Future Oncology .  “Alcohol consumption is one of the most important known risk factors for human cancer and potentially one of the most avoidable factors, but it is increasing worldwide,” the authors of that study wrote. Around 5.8 percent of total cancer-related deaths, or nearly half a million deaths, were directly caused by alcohol in 2012, a group of U.S., Canadian and Italian scientists estimated last year. Summer cocktails. Image: Getty Images for NYX Professional Makeup U.S. alcohol producers pushed back against Connor's analysis. “To declare that alcohol definitively causes cancer based upon cherry-picked epidemiology articles lacks scientific credibility,” Sam Zakhari, senior vice president of scientific affairs for Distilled Spirits Council, a national trade group, said in an emailed statement. “Cancer is a complex disease that is not yet entirely understood and requires more research,” he said.  Connor's report noted the risks of getting cancer from drinking is highest among heavy drinkers , a group roughly defined as men who drink more than four alcoholic beverages a day, and women who drink more than three. But even light consumption — typically one daily drink for women, and two for men — can “minimally” raise the overall cancer risk, Harvard University researchers found in a 2015 paper . In the U.S., one drink is equal to a 12 ounce can of beer, a 5 ounce glass of wine, or 1.5 ounces of 80-proof distilled spirits, according to the American Cancer Society. Those risks multiply for people who both drink and regularly smoke, particularly when it comes to cancers of the mouth, pharynx, larynx and esophagus, Connor said.  A 12 ounce beer equals one drink. Image: Getty Images That doesn’t mean people who drink are necessarily doomed to get those cancers. And there’s some evidence that people who ditch alcohol can reduce their risks of liver, laryngeal and pharyngeal cancers, according to the Addiction report. Still, Connor noted that, while heavy drinkers face higher cancer risks, low to moderate drinkers still experience a “considerable burden” of health hazards from alcohol. Yet many people don’t know about the risks, a problem Connor partly attributed to the news of alcohol’s potential benefits. In an interview with the Guardian , Jana Witt, a health information officer at Cancer Research U.K., applauded the study and offered a few simple tips for lowering alcohol consumption. “Having some alcohol-free days each week is a good way to cut down on the amount you’re drinking,” Witt said. “Also, try swapping every other alcohol drink for a soft drink, choosing smaller servings or less alcoholic versions of drinks, and not keeping a stock of booze at home.” This article was updated to include comment from Distilled Spirits Council.



Researchers successfully block colon cancer tumor growth

Over one million men and women are living with colorectal cancer in the USA.Researchers in the USA have discovered that reducing the amount of the L-glutamine amino acid in the body can block the growth of colorectal cancer tumors in mice. The first clinical trials on humans are due to begin this summer. Recent research has established that cancerous tumors rely on L-glutamine to survive and grow. In this latest study, scientists found that a subset of colorectal cancer cells containing a genetic mutation called PIK3CA -- a commonly occurring mutation in cancer cells -- were particularly high consumers of L-glutamine when growing.



Alcohol Can Cause Certain Cancers, Study Says
Drinking alcohol may cause seven different types of cancer, a new meta-analysis finds. Previous studies have found an association between drinking alcohol and a higher risk of developing certain cancers, according to the study. In the new meta-analysis, published today (July 21) in the journal Addiction, researchers looked at the major review studies done over the last decade on alcohol and cancer, including reviews from the American Institute for Cancer Research and the International Agency for Research on Cancer.

China Resources, Macquarie team up to buy control of Australia healthcare firm GenesisCare

Macquarie Group's logo is pictured on the wall of the Sydney headquarters after the Australian bank's full year results were announcedBy Byron Kaye SYDNEY (Reuters) - Chinese state-owned conglomerate China Resources Group and Australian bank Macquarie Group Ltd plan to buy majority control of GenesisCare Ltd, laying the groundwork for Australia's biggest cancer and cardiac services provider to expand into the world's second-largest economy. In a joint statement on Friday, Hong Kong-based China Resources and Australia's biggest investment bank said they will buy between 50 percent and 74 percent of GenesisCare, without saying how much they will pay. A person with direct knowledge of the deal told Reuters the deal gave GenesisCare, which doesn't disclose annual revenue, an enterprise value of A$1.7 billion ($1.3 billion).



Scientists hunt 'anti-evolution' drugs in new cancer fight

Scientist prepares protein samples for analysis in a lab at the Institute of Cancer Research in SuttonBy Ben Hirschler LONDON (Reuters) - Scientists are opening a new front in the war on cancer with plans to develop "anti-evolution" drugs to stop tumor cells from developing resistance to treatment. Britain's Institute of Cancer Research (ICR), one of the world's top cancer centers, said on Friday its initiative was the first to have at its heart the target of overcoming cancer evolution and drug resistance. In the same way that bacteria evolve resistance to antibiotics, cancer cells also change to evade the medicines used to fight them, leading to "survival of the nastiest".



Amgen, Allergan biosimilar found as effective as Roche cancer drug

File photo of an Amgen sign at the company's office in South San Francisco(Reuters) - Amgen Inc and Allergan Plc said their copycat version of Roche Holding AG's blockbuster cancer treatment, Herceptin, was found as effective as the original in a late-stage study. There were no "clinically meaningful" differences in data gathered from patients given Herceptin and the copycat version, ABP 980, to treat a type of early breast cancer, said Sean Harper, Amgen's executive vice president of research and development.



Roche beats forecasts on new drugs and one-off gain

Roche tablets are seen in this photo illustration shot in ZenicaBy Ludwig Burger BASEL, Switzerland (Reuters) - Switzerland's Roche beat market expectations for adjusted net income in the first six months of the year, helped by cancer drug sales but also inflated by a one-off gain from its pensions scheme. Core earnings per share, adjusted for certain items, rose 7 percent to 7.74 Swiss francs ($7.86), where analysts had expected 7.52 francs on average. Deutsche Bank analyst Tim Race said that excluding that effect, results were broadly in line with expectations.



Hawaii Democratic congressman Mark Takai dies

FILE- This Nov. 4, 2014 file photo shows then-Hawaii Democratic Congressional candidate, State Rep Mark Takai in Honolulu. Takai died at his home on Wednesday, July 20, 2016, after battling cancer. (AP Photo/Marco Garcia, File)HONOLULU (AP) — U.S. Rep. Mark Takai, a war veteran and long-time legislator known for his bright nature and deep commitment to service, died in his home after a months-long battle with cancer.



1    2    3    4    Next